Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jyothy John"'
Autor:
Yuan Chen, Su Liang, Xiuqing Gao, Sunil Krishnan, Pankaj Singh, Oscar Ekpenyong, Huan Xie, Jon A. Schwartz, Jing Ma, Maureen Aliru, Jyothy John, Yuanqing Ye, Amit Deorukhkar, Xiaomei Bian
Publikováno v:
Oncotarget
Tumor hypoxia is a well-recognized driver of resistance to traditional cancer therapies such as chemotherapy and radiation therapy. We describe development of a new nanoconstruct composed of gold nanorods (GNRs) conjugated to carbonic anhydrase IX (C
Publikováno v:
British Journal of Pharmacology. 168:1851-1858
Background and Purpose Warfarin is often used with etravirine (ETV) to prevent HIV-related thromboembolic events. As both warfarin and ETV bind to plasma proteins and are metabolized by hepatic cytochrome P450s, they are likely to interact. Hence, we
Publikováno v:
Journal of Chromatography B. 878:3181-3186
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is active against NNRT-resistant HIV-1. A simple, sensitive, and specific LC-MS/MS method was developed and validated for the analysis of etravirine in rat plasma using itrac
Autor:
Dong Liang, Jyothy John
Publikováno v:
Journal of Bioequivalence & Bioavailability.
Aim: Etravirine is the first drug in the second generation of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs). Despite its use in clinical management of HIV infected patients, the drug has very limited bioavailability due to low water solubi
Autor:
Jyothy John, Keila Robinson, Cyril V. Abobo, Mathew John, Jason Caballero, Dong Liang, Jing Ma
Publikováno v:
Tandem Mass Spectrometry-Applications and Principles
Warfarin, one of the most commonly used oral anticoagulant in the US and across the globe, is a drug of choice for millions. It’s a unique drug of its kind due to the multiple pharmacological and pharmacokinetic properties. The posology of warfarin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f72c3931581235f4d47b322e45172fb
https://doi.org/10.5772/32204
https://doi.org/10.5772/32204
Publikováno v:
International Journal of Nanomedicine
Xiaomei Bian,1 Su Liang,1 Jyothy John,1 Cheng-Hui Hsiao,1 Xin Wei,2 Dong Liang,1 Huan Xie1 1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, 2Department of Chemistry, College of Science and Technology, Texas Southern Un
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.